stock.name

Zymeworks BC Inc

ZYME

Market Cap$751.55M
Close$

Compare Zymeworks BC

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zymeworks BC IncZymeworks BC Inc-3.20%-107%--
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$15.63

Current Fair Value

51.7% upside

Undervalued by 51.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$751.55 Million
Enterprise Value$509.83 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-4.06
Beta1.14
Outstanding Shares70,568,222
Avg 30 Day Volume672,323

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-3.17
PEG73.76
Price to Sales-
Price to Book Ratio3.43
Enterprise Value to Revenue16.12
Enterprise Value to EBIT-2.12
Enterprise Value to Net Income-3
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Zymeworks Inc

CEO: Ali Tehrani